Greenberg Traurig's Nancy Taylor to Speak on Food and Drug Law Institute's Live Webinar

Nancy E. Taylor, co-chair of the Health Care & FDA Practice of global law firm Greenberg Traurig, LLP, will speak on the Food and Drug Law Institute's (FDLI) Live Webinar Jan. 25 from 2:00-3:30 p.m.

WASHINGTON, Jan. 24, 2023 /PRNewswire-PRWeb/ -- Nancy E. Taylor, co-chair of the Health Care & FDA Practice of global law firm Greenberg Traurig, LLP, will speak on the Food and Drug Law Institute's (FDLI) Live Webinar Jan. 25 from 2:00-3:30 p.m.

The panel, titled "Implementation of the Inflation Reduction Act: Healthcare Reform and Implications for the Pharmaceutical Industry," will discuss "the multi-faceted implications of the IRA on industry and the state of public health, as well as benefits and risks posed by implementing this framework, including impacts on prescription drug affordability, generic drugs, orphan drug exclusivity, differential treatment between small molecules and biologics, and strategy shifting for industry," according to FDLI.